Rapamycin: Rapamycin Holdings Plans Tests of Old Immune Drug in Prostate Cancer

San Antonio - Executives at Rapamycin Holdings believe a decades-old drug used to prevent organ transplant rejection could find a new use as a treatment for prostate cancer, and hope to begin a clinical trial as soon as this summer. San Antonio-based Rapamycin Holdings has developed a new formulation of the drug, also called rapamycin, which [...]